KeyBanc Raises Price Target for UnitedHealth Group (NYSE: UNH) Amid Strong AI Investments and Profit Growth

• KeyBanc raised its price target for UnitedHealth Group to $475.00, maintaining an Overweight rating, reflecting confidence in the healthcare stock's future performance.
• UnitedHealth Group's $1.5 billion investment in artificial intelligence (AI) is expected to yield a 2-to-1 return, driving operational efficiencies and justifying a higher valuation.
• Despite a projected 1.4% decline in revenue, strong earnings per share growth of 18.6% to $4.84 is anticipated, supported by improved medical cost management.

On July 14, 2026, analyst firm KeyBanc raised its price target for UnitedHealth Group (NYSE: UNH) to $475.00 from $400.00. UnitedHealth Group, a prominent healthcare and insurance company, continues to draw positive attention. KeyBanc maintained its Overweight rating, which suggests the analyst believes the healthcare stock will perform better than the broader market. At the time, UnitedHealth Group traded at $429.09.

This positive analyst view is supported by UnitedHealth Group's major strategic investments. UnitedHealth Group is investing approximately $1.5 billion into artificial intelligence (AI) across its operations this year. Management expects a 2-to-1 return on this significant AI investment, which can justify a higher valuation and supports the analyst's increased price target.

UnitedHealth Group is already seeing measurable results from its AI strategy. These include faster prior authorizations for medical procedures, fewer appeals from members, and lower call-center volumes. Management notes that many of the new AI tools are expected to pay for themselves within 12 to 18 months, demonstrating a quick return on investment and enhancing operational efficiency.

Expectations for strong profitability also reinforce the positive investment outlook ahead of UnitedHealth Group's second-quarter earnings report. As highlighted by Zacks Investment Research, UnitedHealth Group is projected to report earnings of $4.84 per share. This figure represents a significant 18.6% increase from the same period last year, signaling robust profit growth.

While earnings are growing, revenue is expected to see a slight decline. Projections show revenue at $110.05 billion, a 1.4% decrease year-over-year, partly due to a decrease in memberships. However, improved management of medical costs is expected to positively influence profitability, and UnitedHealth Group trades below competitors like Humana, suggesting potential for further market performance.